For example, immunohistochemistry (IHC) was used to detect ER(−), PR(−) and HER2(−) protein expression in patient tumor samples; tumor proliferation indices were assessed by IHC methods, and high expression of Ki-67 was associated with more aggressive tumor growth rates. This evidence concerns the gene ERBB2 and neoplasm.